Adoptive T-cell immunotherapy offers promise to patients who are resistant to standard anti-viral strategies. Here the authors describe clinical observations in patients with viral complications treated with adoptive immunotherapy over the last 15 years.
- Michelle A. Neller
- George R. Ambalathingal
- Rajiv Khanna
